1.
Tursi A, Tiano M. SARS-COV-2 infection might cause transient cutaneous lesions in IBD patients under treatment with adalimumab. JGLD [Internet]. 19Jun.2021 [cited 29Nov.2021];30(2):310-1. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/3572